LSK BioPharma
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(801) 303-7440Website
www.lskbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About LSK BioPharma
LSKB is a privately-held biopharmaceutical company based in Salt Lake City, Utah. The Company specializes in the early clinical development of promising therapies for unmet medical needs in cancer. LSKB is developing two exciting drug candidates; a small molecule angiogenesis inhibitor with potential to treat a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Explore more
LSK BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LSK BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at LSK BioPharma
LSK BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if LSK BioPharma had a recent Job posting/layoffs
Earning: See what the market has to say on LSK BioPharma recently announced quarterly report
Check if LSK BioPharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when LSK BioPharma launches new products
Funding: Get notified immidiatlly once LSK BioPharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if LSK BioPharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
LSK BioPharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LSK BioPharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LSK BioPharma.
LSK BioPharma News & Media
LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical Collaboration to Evaluate the Combination of Anti-Angiogenesis and Immuno-Oncology Therapy for Patients with Advanced Hepatocellular Carcinoma (HCC)
SALT LAKE CITY and SHANGHAI, Oct. 21, 2018 /PRNewswire/ -- LSK BioPharma (or "LSKB"), a US-based biopharmaceutical firm and Jiangsu Hengrui Medicine, Co., Ltd. (SHA:600276, or "Hengrui"), one of the largest and most innovative fully-integrated biopharmaceutical companies based in China,...LSKB Announces Official Nonproprietary Naming of Apatinib (YN968D1): RIVOCERANIB
SALT LAKE CITY, Jan. 2, 2018 /PRNewswire/ -- LSKB announced that it has adopted the nonproprietary/generic name "rivoceranib" (pronounced riv" oh ser' an ib) for its small molecule angiogenesis inhibitor commonly known as apatinib and YN968D1. "Rivoceranib" has been approved as the...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LSK BioPharma
Sign Up For FreeTo access detailed company insights
LSKB is a privately-held biopharmaceutical company based in Salt Lake City, Utah. The Company specializes in the early clinical development of promising therapies for unmet medical needs in cancer. LSKB is developing two exciting drug candidates; a small molecule angiogenesis inhibitor with potential to treat a variety of solid tumors and a BTK/JAK... Read More
